Lv4
753 积分 2021-06-09 加入
Iptacopan in IgA Nephropathy — Final 24-Month Data
2天前
已完结
In situ assessment of glomerular C3/C5 convertases indicates ongoing complement activation in IgA nephropathy
2天前
已完结
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
2天前
已完结
Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes
2天前
已完结
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study
2天前
已完结
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
3天前
已完结
Ravulizumab Plus Best Supportive Care in Pediatric Patients with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: 52-Week Results from a phase 3 Trial
3天前
已完结
Early eculizumab treatment improves renal outcomes in pediatric lupus nephritis with thrombotic microangiopathy
3天前
已完结
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
3天前
已完结
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin–Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial
3天前
已完结
皖公网安备34019202002308
